David Gonyer
Keine laufenden Positionen mehr
Vermögen: 14 284 $ am 31.03.2024
Profil
David A.
Gonyer was the founder of Xcel Pharmaceuticals, Inc. (founded in 2000) where he held the title of Vice President-Sales & Marketing from 2000 to 2004.
He was also the founder of Evoke Pharma, Inc. (founded in 2007) where he served as Chief Executive Officer & Director from 2023 to 2024.
In addition to his founding positions, Mr. Gonyer has held former jobs.
He worked as a Marketing Director at Dura Pharmaceuticals, Inc. from 1996 to 2000.
He was a Director at Neurelis, Inc. from 2010 to 2015.
He served as an Independent Director at Signal Genetics, Inc. from 2014 to 2017.
Prior to his founding roles, he worked at Eli Lilly & Co. as a Principal from 1987 to 1996.
He also held the position of Vice President-Strategic & Product Development at Medgenex, Inc. from 2004 to 2007.
Mr. Gonyer's education history includes an undergraduate degree from Ferris State University (Michigan).
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
EVOKE PHARMA, INC.
0,28% | 13.03.2023 | 23 416 ( 0,28% ) | 14 284 $ | 31.03.2024 |
Ehemalige bekannte Positionen von David Gonyer
| Unternehmen | Position | Ende |
|---|---|---|
| EVOKE PHARMA, INC. | Founder | 31.03.2024 |
Signal Genetics, Inc.
 Signal Genetics, Inc. Medical/Nursing ServicesHealth Services Signal Genetics, Inc. is a commercial stage, molecular diagnostic company. It provides innovative diagnostic services that help physicians make better-informed decisions concerning the care of their patients suffering from cancer. The company was founded in January 2010 and is headquartered in Carlsbad, CA. | Director/Board Member | 13.02.2017 |
Neurelis, Inc.
 Neurelis, Inc. Pharmaceuticals: MajorHealth Technology Neurelis, Inc. operates as a specialty pharmaceutical company. It is organized to license, develop and commercialize product candidates for the treatment of central nervous system disorders with a focus on the acute treatment of epilepsy and anxiety episodes. The company was founded by Craig C. Chambliss and David F. Hale in 2007 and is headquartered in San Diego, CA. | Director/Board Member | 01.01.2015 |
| Medgenex, Inc. | Corporate Officer/Principal | 01.03.2007 |
Xcel Pharmaceuticals, Inc.
 Xcel Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Xcel Pharmaceuticals, Inc. used to manufactures pharmaceutical products. The company was engaged in prescription products that treat disorders of the central nervous system. Its portfolio included four products, two that were used to treat epilepsy and two that were used to treat migraine. The company was founded in 2001 by Cam L. Garner and was headquartered in San Diego, CA | Founder | 01.12.2004 |
Ausbildung von David Gonyer
| Ferris State University (Michigan) | Undergraduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 2 |
|---|---|
| ELI LILLY AND COMPANY | Health Technology |
| EVOKE PHARMA, INC. | Health Technology |
| Private Unternehmen | 5 |
|---|---|
Dura Pharmaceuticals, Inc.
 Dura Pharmaceuticals, Inc. BiotechnologyHealth Technology Dura Pharmaceuticals, Inc. markets and sells prescription products that treat infectious and respiratory diseases. Dura focuses on products and transactions that leverage its sales and marketing organization. Dura also intends, through the use of collaborative relationships, to develop the Spiros® motorized blisterdisk and Spiros® S2 pulmonary drug delivery systems for the local and systemic delivery of a wide range of medications. It is located in San Diego, CA. | Health Technology |
Xcel Pharmaceuticals, Inc.
Xcel Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Xcel Pharmaceuticals, Inc. used to manufactures pharmaceutical products. The company was engaged in prescription products that treat disorders of the central nervous system. Its portfolio included four products, two that were used to treat epilepsy and two that were used to treat migraine. The company was founded in 2001 by Cam L. Garner and was headquartered in San Diego, CA | Health Technology |
Neurelis, Inc.
Neurelis, Inc. Pharmaceuticals: MajorHealth Technology Neurelis, Inc. operates as a specialty pharmaceutical company. It is organized to license, develop and commercialize product candidates for the treatment of central nervous system disorders with a focus on the acute treatment of epilepsy and anxiety episodes. The company was founded by Craig C. Chambliss and David F. Hale in 2007 and is headquartered in San Diego, CA. | Health Technology |
Signal Genetics, Inc.
Signal Genetics, Inc. Medical/Nursing ServicesHealth Services Signal Genetics, Inc. is a commercial stage, molecular diagnostic company. It provides innovative diagnostic services that help physicians make better-informed decisions concerning the care of their patients suffering from cancer. The company was founded in January 2010 and is headquartered in Carlsbad, CA. | Health Services |
| Medgenex, Inc. |
